Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

EQS-News: Q1 2023: DWS Returns to Net Inflows
EQS-News: Q1 2023: DWS Returns to Net Inflows
EQS-News: Q1 2023: DWS Returns to Net Inflows
EQS-News: Instone Real Estate Group SE announces CFO change
EQS-News: Instone Real Estate Group SE announces CFO change
EQS-News: Instone Real Estate Group SE announces CFO change
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Karl von Rohr to step down as DWS Chairman in October
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Karl von Rohr to step down as DWS Chairman in October
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Karl von Rohr to step down as DWS Chairman in October
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Releases Annual Report and Announces Dividend Proposal
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Releases Annual Report and Announces Dividend Proposal
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Releases Annual Report and Announces Dividend Proposal
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-Adhoc: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-Adhoc: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-News: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-News: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-News: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023
EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023
EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023
EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share
EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share
EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share
EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend
EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend
EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend
EQS-News: HENSOLDT grows significantly in 2022 financial year and stands ready as strong technology partner for the “Zeitenwende”
EQS-News: HENSOLDT grows significantly in 2022 financial year and stands ready as strong technology partner for the “Zeitenwende”
EQS-News: HENSOLDT grows significantly in 2022 financial year and stands ready as strong technology partner for the “Zeitenwende”
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Remains on the Path to Success Even in a Year of Global Crisis
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Remains on the Path to Success Even in a Year of Global Crisis
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Remains on the Path to Success Even in a Year of Global Crisis
EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes
EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes
EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation
EQS-News: SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation
EQS-News: SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation
EQS-Adhoc: SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB
EQS-Adhoc: SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB
EQS-Adhoc: SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB
EQS-News: HENSOLDT AG accelerates growth and raises targets
EQS-News: HENSOLDT AG accelerates growth and raises targets
EQS-News: HENSOLDT AG accelerates growth and raises targets